English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

sions with ostial LCX stenting. The follow-up angiography was performed at 8 months after procedure. Exclusion criteria included the following: bare metal stenting, hybrid stenting, in-stent restenosis at the ostial site of the LCX, trifurcation lesions, and previous LMT to left anterior descending coronary artery crossover stenting. The primary endpoints of our study were main and side branch restenoses and target lesion revascularization (TLR) at 8-month followup. Results: In LMT-LCX crossover stenting and ostial LCX stenting, the restenosis rates were 20.5% (8/39) and 40.1% (9/22) (p=0.008), the TLR rates were 12.8% (5/39) and 36.4% (8/22) (p=0.0031), and the clinically driven TLR rates were 7.7% (3/39) and 13.7% (3/22) (p=03458). Conclusion: The TLR rate was higher in ostial LCX stenting than in LMT-LCX crossover stenting. LMT-LCX crossover stenting may be more favorable if possible.

european heart journal

Everolimus- and sirolimus-eluting stents in patients with and without ST-elevation myocardial infarction: two year pooled results from the XAMI and APPENDIX-AMI trials